Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
283 participants
INTERVENTIONAL
2004-02-29
2012-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trauma Intervention for Affect Regulation, AIDS, and Substances
NCT02923141
Group Psychotherapy for People With HIV
NCT00186550
Computer-Based Intervention in HIV-Positive Young Adults
NCT02544126
Intervention to Assist MSM Disclose HIV Status to Casual Sex Partners
NCT02116049
Motivating HIV+ Women: Risk Reduction and ART Adherence
NCT00253045
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Trauma writing
Four sessions of writing about traumatic experiences.
Trauma writing
Writing about daily events
Four sessions of writing about their daily experiences.
Writing about daily events
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trauma writing
Writing about daily events
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 8 years of formal education
* Literate
* Fluent in English
All of the following three must apply:
* No active Category C HIV AIDS-defining symptoms
* CD4 T-lymphocyte count between 150-499
* Viral load \>1000
Exclusion Criteria
* Illiterate or non-English speaking
* Active systemic diseases that would interfere with participation
* Current alcohol or substance dependence
* Planned change in HIV medication in the next 6 months, or recent change in past 2 months
* Introduction of antidepressant medication within 30 days of study start
* Current psychological counseling, cognitive behavior therapy, support group or other psychological therapy, or plans to start any of the above
* Diagnosis of PTSD or major depression
* Unable to attend at least 4 treatment sessions
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Complementary and Integrative Health (NCCIH)
NIH
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gail Ironson
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gail Ironson, MD
Role: PRINCIPAL_INVESTIGATOR
University of Miami Dept. of Psychology & Behavioral Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami Dept. of Psychology & Behavioral Medicine
Coral Gables, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20020511
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.